IRIS
RUSCITTI, PIERO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.649
EU - Europa 2.862
AS - Asia 1.066
SA - Sud America 15
Continente sconosciuto - Info sul continente non disponibili 10
OC - Oceania 7
AF - Africa 2
Totale 8.611
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.637
IE - Irlanda 1.392
CN - Cina 579
SE - Svezia 334
TR - Turchia 286
IT - Italia 273
DE - Germania 257
UA - Ucraina 220
GB - Regno Unito 128
SG - Singapore 122
FR - Francia 72
FI - Finlandia 71
BE - Belgio 35
VN - Vietnam 30
IN - India 29
CZ - Repubblica Ceca 22
RU - Federazione Russa 17
BR - Brasile 9
EU - Europa 9
CA - Canada 8
GR - Grecia 7
CH - Svizzera 6
HK - Hong Kong 6
RO - Romania 6
AU - Australia 5
NL - Olanda 4
ES - Italia 3
LU - Lussemburgo 3
MK - Macedonia 3
AT - Austria 2
CO - Colombia 2
DK - Danimarca 2
ID - Indonesia 2
IL - Israele 2
MO - Macao, regione amministrativa speciale della Cina 2
NZ - Nuova Zelanda 2
PE - Perù 2
PH - Filippine 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AR - Argentina 1
BS - Bahamas 1
CI - Costa d'Avorio 1
CL - Cile 1
HR - Croazia 1
IR - Iran 1
JP - Giappone 1
KR - Corea 1
KZ - Kazakistan 1
LB - Libano 1
MD - Moldavia 1
MM - Myanmar 1
MX - Messico 1
NO - Norvegia 1
PA - Panama 1
PL - Polonia 1
PR - Porto Rico 1
PT - Portogallo 1
ZA - Sudafrica 1
Totale 8.611
Salva come PNG Salva come JPEG
Città #
Dublin 1.389
Chandler 1.137
Jacksonville 942
New York 224
Izmir 208
Ashburn 162
Lawrence 161
Princeton 161
Ann Arbor 151
Boardman 145
Nanjing 125
Wilmington 123
Beijing 102
L'aquila 99
San Mateo 83
Singapore 81
Dearborn 63
Los Angeles 63
Woodbridge 55
Nanchang 49
Milan 45
Seattle 32
Shanghai 32
Brussels 31
Dallas 30
Dong Ket 30
Mountain View 30
Shenyang 29
Des Moines 28
Kunming 28
L’Aquila 26
Hebei 24
Brno 20
Jinan 20
Kitzingen 19
Verona 19
Jiaxing 18
Tianjin 18
Cedar Knolls 17
Zhengzhou 17
Pune 16
Houston 15
Changsha 14
Helsinki 14
Munich 12
Ningbo 12
Norwalk 12
Bremen 11
Hangzhou 11
Hefei 11
Lappeenranta 10
Washington 10
Philadelphia 9
Frankfurt am Main 8
Grafing 8
Guangzhou 8
Edinburgh 7
Changchun 6
Redwood City 6
Stockholm 6
Fremont 5
Lanzhou 5
Moscow 5
Phoenix 5
Rome 5
Berlin 4
Chengdu 4
Hong Kong 4
Jinhua 4
Leuven 4
Pescara 4
Ponte A Égola 4
Santa Clara 4
St Petersburg 4
Taizhou 4
Zurich 4
Aquila 3
Auburn Hills 3
Forest City 3
Naples 3
Paris 3
Redmond 3
Amsterdam 2
Athens 2
Atlanta 2
Auckland 2
Brisbane 2
Bucharest 2
Cassano d'Adda 2
Charlotte 2
Chicago 2
Civitella Messer Raimondo 2
Fairfield 2
Fuzhou 2
Intra 2
Leeds 2
Lima 2
London 2
Madrid 2
Manila 2
Totale 6.365
Salva come PNG Salva come JPEG
Nome #
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 109
FRI0613 H-ferritin and pro-inflammatory cytokines are increased in the bone marrow of adult patients affected by macrophage activation syndrome 99
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 97
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 93
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 93
Prognostic factors of adult onset Still’s disease: analysis of 100 cases in 3 tertiary referral centers 92
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 89
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients. 89
association of pathogenic and regulatory B-cell subsets with clinical and histological features in primary Sjogren's syndrome. 89
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 88
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis. 88
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 88
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 86
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 84
Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis 83
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 81
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 79
Stromal Cell-derived Factor 1 in Cardiac and Autoimmune Disease 78
Stem cell therapies for systemic sclerosis 77
A comprehensive review on adult onset Still's disease 77
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 76
Macrophage activation syndrome in Still's disease: analysis of clinical characteristics and survival in paediatric and adult patients. 76
Impaired Cav-1 expression in SSc mesenchymal cells upregulates VEGF signaling: a link between vascular involvement and fibrosis 75
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 74
EFFICACY AND SAFETY OF RITUXIMAB TREATMENT IN EARLY PRIMARY SJOGREN'S SYNDROME: A CLINICAL, HISTOLOGICAL AND MOLECULAR STUDY 73
Cardiovascular disease in primary sjögren’s syndrome 73
Methotrexate in rheumatoid arthritis: optimizing therapy among different formulations. Current and emerging paradigms 72
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 72
SENESCENT BONE MARROW DERIVED MESENCHYMAL STEM CELLS (MSC) ARE PRONE TO RECOVER DURING SSC 71
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 71
Efficacy of inhibition of IL-1 in patients with rheumatoid arthritis and type 2 diabetes mellitus: two case reports and review of the literature. 70
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features. 70
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 69
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 69
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 69
Interleukin-9 Overexpression and Th9 Polarization Characterize the Inflamed Gut, the Synovial Tissue, and the Peripheral Blood of Patients With Psoriatic Arthritis 69
Searching for a good model for systemic sclerosis: The molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis 68
Decreased Expression of Angiopoetin 1 on Perivascular Mesenchymal Stem Cells from Ssc Patients Induces an Anti Angiogenetic Effect, when Co-cultured with Endothelial Cells 67
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study. 67
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis: Results from a cross-sectional study. 66
Interstitial lung disease in systemic sclerosis: current and future treatment. 66
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 65
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 63
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies a very early cardiac involvement in systemic sclerosis patients of recent onset 62
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands 61
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 61
Methotrexate: an old new drug in autoimmune disease. 59
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 59
Caveolin-1 orchestrates vascular endothelial growth factor (VEGF) signaling control of angiogenesis during systemic sclerosis (SSC) 59
T helper 1 response is correlated with widespread pain, fatigue, sleeping disorders and the quality of life in patients with fibromyalgia and is modulated by hyperbaric oxygen therapy 58
Interleukin (IL)-9/IL-9R axis drives γδ T cells activation in psoriatic arthritis patients 57
Computed Tomography and MR Imaging in Rheumatoid Arthritis 57
Tocilizumab for the treatment of adult-onset Still's disease: Results from a case series 57
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 56
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. 55
Response to: ‘Correspondence on ‘Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence–radiological differences’ by Ruscitti et al’ by Chen et al 55
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 54
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with sjogren’s syndrome 53
Senescent bone marrow mesenchymal stem cells (BM-MSCS) preserve their immune-regulatory effect on t cells during systemic sclerosis (SSC). 53
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 53
Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine. 53
Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases 52
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 52
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 52
Early assessment of sub-clinical cardiac involvement in systemic sclerosis (SSc) using delayed enhancement cardiac magnetic resonance (CE-MRI). 52
Persistence of focal lymphocytic sialadenitis in patients with primary Sjögren's syndrome treated with rituximab: a possible role for glandular BAFF 52
Prescribing motivations and patients' characteristics related to the use of biologic drugs in adult-onset Still's disease: analysis of a multicentre "real-life" cohort 51
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences 51
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 51
POTENTIAL OF STEM CELLS IN THE TREATMENT OF RHEUMATIC DIDEASE 50
Angiogenic cytokines and growth factors in systemic sclerosis. 50
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study 50
IL LABORATORIO IN REUMATOLOGIA 50
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 50
The effect of non-TNF-targeted biologics on vascular dysfunction in rheumatoid arthritis: A systematic literature review 50
Il laboratorio nelle malattie reumatiche 49
Macrophage activation syndrome in patients affected by adult-onset still disease: Analysis of survival rates and predictive factors in the Gruppo Italiano di Ricerca in reumatologia clinica e sperimentale cohort 49
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 49
CARDIAC MAGNETIC RESONANCE IMAGING WITH PHARMACOLOGICAL STRESS PERFUSION IN ASYMPTOMATIC PATIENTS WITH SYSTEMIC SCLEROSIS 49
IL-9 over-expression and Th9 polarization in Systemic Sclerosis patients 48
Cardiovascular and Metabolic Comorbidities in Rheumatoid Arthritis 48
Dissecting the clinical heterogeneity of adult-onset Still's disease, results from a multi-dimensional characterisation and stratification 48
Evaluating the multivisceral involvement on adult-onset Still’s disease to retrieve imaging-based differences in patients with and without macrophage activation syndrome: results from a single-centre observational study 48
 Epidermal growth factor-like domain 7 (EGFL7) in skin of systemic sclerosis 47
The Vessels Contribute to Fibrosis in Systemic Sclerosis 47
Low-dose aspirin as primary prophylaxis for cardiovascular events in rheumatoid arthritis: an Italian multicentre retrospective study 47
Guidelines for biomarkers in autoimmune rheumatic diseases - evidence based analysis 47
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 46
Managing Adult-onset Still's disease: The effectiveness of high-dosage of corticosteroids as first-line treatment in inducing the clinical remission. Results from an observational study 46
Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trial 46
The wide spectrum of Kawasaki-like disease associated with SARS-CoV-2 infection 46
VASCULAR SMOOTH MUSCLE CELLS (SMC) PROGENITORS: NEW PLAYERS IN SYSTEMIC SCLEROSIS (SSC) DEFECTIVE VESSEL REGENERATION. 44
Severe COVID-19 and related hyperferritinaemia: more than an innocent bystander? 44
Diagnostic and interventional radiology fundamentals of synovial pathology 44
Il Laboratorio nelle malattie autoimmuni sistemiche 43
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 43
2-Arachidonoylglycerol Reduces the Production of Interferon-Gamma in T Lymphocytes from Patients with Systemic Lupus Erythematosus 42
Laboratory assessment in patients with suspected rheumatic musculoskeletal diseases: challenges, pitfalls and perspectives 42
Interleukin-25 Axis Is Involved in the Pathogenesis of Human Primary and Experimental Murine Sjögren's Syndrome 42
Oxidized low density lipoproteins: The bridge between atherosclerosis and autoimmunity. Possible implications in accelerated atherosclerosis and for immune intervention in autoimmune rheumatic disorders 42
Totale 6.251
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.880
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.880
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020917 0 12 107 23 24 172 169 33 129 61 22 165
2020/20211.193 31 132 23 155 155 48 157 21 153 44 206 68
2021/2022803 39 24 153 63 17 12 31 42 66 44 61 251
2022/20233.501 226 193 60 362 209 328 49 217 1.676 21 119 41
2023/20241.043 117 46 69 99 76 325 31 54 22 59 41 104
2024/2025175 118 57 0 0 0 0 0 0 0 0 0 0
Totale 8.941